Researchers found that many Canadians with serious lung conditions are facing delays in accessing new therapies that could improve their health and survival. The Lung Health Foundation is urging the Canadian government to modernize the current system, which can leave patients waiting for treatments that are already available in other countries. This is especially critical for conditions like lung cancer, chronic obstructive pulmonary disease (COPD), and asthma, where timely access to advanced therapies can make a significant difference in outcomes.

For people dealing with these respiratory issues, faster access to emerging treatments could mean better quality of life and extended survival. Lung cancer is the leading cause of cancer death in Canada, with an estimated 19,300 deaths expected this year. The proposed changes would allow doctors to more quickly obtain therapies when no comparable treatment is available in Canada, potentially saving lives and improving care for critically ill patients.

Currently, the Special Access Program (SAP) allows physicians to request treatments not yet authorized for general use, but the process can be slow and cumbersome. A new Private Member’s Bill, C-265, aims to streamline this access by creating a pre-approved list of therapies, allowing for quicker responses to urgent medical needs. While the bill has garnered cross-party support, it still emphasizes that safety standards will not be compromised.

As medical knowledge advances rapidly, the gap between available treatments and patient access in Canada is becoming increasingly frustrating for doctors and patients alike. The Lung Health Foundation believes that by making access to therapies more agile, Canada can better support its patients and keep pace with medical innovation.

Source: globenewswire.com